Key Takeaways
- • EQT's £7.9bn ($10.74bn) takeover proposal rejected by Intertek — The Swedish private equity firm's non-binding offer priced the FTSE 100 testing and certification company at 51.5 pounds per share, representing a 36.6% premium to the closing price on April 9, but Intertek's board determined the bid materially undervalued the business.
- • Intertek pursuing strategic alternatives including potential division separation — The company is conducting its own strategic review focused on unlocking shareholder value, with consideration of separating its two business divisions alongside assessing external interest from both financial and strategic buyers.
- • Strong operational momentum supports Intertek's rejection stance — The company reported 5.4% like-for-like revenue growth in Q1 2026 and reaffirmed mid-single-digit growth guidance for the full year, providing fundamental support for management's assertion that EQT's valuation was insufficient.
- • Deal rejection likely to catalyze increased bidder interest — Analysts expect the proposal rejection and ongoing strategic review to attract additional competitive bids from both private equity and strategic acquirers, supported by elevated interest in UK-listed industrial and services companies trading at relatively subdued valuations.
- • Sector peers benefited from deal announcement momentum — Testing and certification companies saw share price gains reflecting broader sector appetite, as demand for compliance, sustainability, and quality assurance services continues expanding across global supply chains.
Summary
The rejection announcement triggered significant share price appreciation for Intertek, reflecting market expectations that the company possesses considerably greater intrinsic value than EQT's non-binding offer suggested. The move has positioned the company within an increasingly competitive M&A environment for UK-listed industrial and business services assets, which have attracted growing private equity and strategic buyer attention amid relatively attractive valuations compared to broader market multiples.
Intertek is simultaneously executing its own strategic review, which includes evaluation of a potential separation of its two business divisions as a mechanism to unlock incremental shareholder value. EQT has indicated it is reviewing its options following the rejection, signaling the door remains open to revised proposals or alternative transaction structures. Market participants widely expect that the rejection and announcement of a formal strategic review will generate additional bidding interest from competing financial sponsors and strategic acquirers across the industrial services and testing sectors.
Intertek's operational performance supports management's valuation defense. The company reported 5.4% like-for-like revenue growth during the first quarter of 2026 and maintained mid-single-digit growth guidance for the full fiscal year, demonstrating resilient underlying business momentum. This performance trajectory, combined with secular tailwinds in compliance, sustainability, and quality assurance services within global supply chains, provides a credible foundation for the board's rejection of EQT's initial bid.
Testing and certification sector peers similarly advanced on the announcement, reflecting investor recognition of broader sector demand dynamics and the potential for elevated M&A activity within the space. The increased focus on quality assurance, regulatory compliance, and sustainability verification across international supply chains continues to support organic growth and strategic buyer interest in the sector.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.